MarketPeel
Insider Trading Intelligence
JQ

John D. Quisel

IRON
CHIEF EXECUTIVE OFFICER · DISC MEDICINE, INC. · CIK 0001586788
FILING MIX · LIFETIME41%/59%
BUYS
24
SELLS
34
TOTAL VALUE
$13.72M
COMPANIES
2
ACTIVE SINCE
Dec 2022
HOLDINGS NOW
352,137
AVG SELL PX
$69.26
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 26 pending
Forward-return performance of every backtestable P/S trade by John D. Quisel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+66.67%-1.48%-0.94%-0.54%-1.53%
14d18+77.78%-4.35%-0.81%-3.54%-3.48%
30d18+83.33%-7.83%-0.10%-7.73%-8.47%
60d18+77.78%-11.08%+0.63%-11.72%-15.43%
90d18+77.78%-13.44%-1.30%-12.14%-14.80%
180d18(1 pending)+76.47%-8.52%+4.19%-12.72%-17.86%
1y18(7 pending)+0.00%+29.94%+14.95%+15.00%+9.06%
2y18(18 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IRON · 237,137 shares · as of Jun 18, 2026
065,016130,032195,048260,0642023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 24 buys / 34 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
22,927$69.92$1.60M237,137Jun 18, 2026Jun 23, 2026View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
34,00041,375Jun 18, 2026Jun 23, 2026View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
1,551$71.61$111.1K226,064Jun 18, 2026Jun 23, 2026View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
34,000$9.86$335.2K260,064Jun 18, 2026Jun 23, 2026View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
9,522$70.70$673.2K227,615Jun 18, 2026Jun 23, 2026View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
115,000115,000Jun 4, 2026Jun 5, 2026View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
13,264$62.86$833.8K226,064Feb 17, 2026Feb 17, 2026View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
82,80082,800Feb 10, 2026Feb 11, 2026View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
55,200239,328Feb 10, 2026Feb 11, 2026View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
12,300186,120Dec 19, 2025Dec 19, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
12,300$1.01$12.4K184,128Dec 19, 2025Dec 19, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
4,337$92.21$399.9K205,072Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
16,888$93.65$1.58M171,828Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
2,419$90.97$220.1K209,409Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
40,00075,375Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
40,000$9.86$394.4K211,828Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
16,356$92.96$1.52M188,716Dec 11, 2025Dec 15, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
10,000$1.01$10.1K171,828Sep 9, 2025Sep 11, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
10,000198,420Sep 9, 2025Sep 11, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
34,800115,375Jul 9, 2025Jul 11, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
34,800$9.86$343.1K196,628Jul 9, 2025Jul 11, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
31,207$55.23$1.72M165,421Jul 9, 2025Jul 11, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
3,593$56.20$201.9K161,828Jul 9, 2025Jul 11, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
5,200$55.09$286.5K161,828Jul 3, 2025Jul 8, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
5,200150,175Jul 3, 2025Jul 8, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
5,200$9.86$51.3K167,028Jul 3, 2025Jul 8, 2025View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
115,000115,000Jun 25, 2025Jun 26, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
7,000$1.01$7.1K161,828Apr 7, 2025Apr 8, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
7,000208,420Apr 7, 2025Apr 8, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
5,574$54.58$304.2K154,828Feb 18, 2025Feb 20, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
117,505117,505Feb 10, 2025Feb 12, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
78,337160,402Feb 10, 2025Feb 12, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
10,000215,420Dec 31, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
10,000$1.01$10.1K82,065Dec 31, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
11,112$61.87$687.5K73,965Dec 30, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
13,012155,375Dec 30, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
13,012$9.86$128.3K85,077Dec 30, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
1,900$62.41$118.6K72,065Dec 30, 2024Jan 2, 2025View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
19,82041,830Dec 23, 2024Dec 26, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
12,194$63.12$769.7K76,277Dec 23, 2024Dec 26, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
3,414$62.38$213.0K88,471Dec 23, 2024Dec 26, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
4,212$63.80$268.7K72,065Dec 23, 2024Dec 26, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
19,820$2.65$52.5K91,885Dec 23, 2024Dec 26, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
219$64.66$14.2K84,637Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
12,791225,420Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
12,791$1.01$12.9K84,856Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
5,767$65.58$378.2K78,870Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
500$67.20$33.6K72,065Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
SALE10b5-1
10b5-1 plan
6,305$66.35$418.4K72,565Dec 16, 2024Dec 18, 2024View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
3,000238,211Jul 8, 2024Jul 10, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
3,000$1.01$3.0K72,065Jul 8, 2024Jul 10, 2024View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
115,000115,000Jun 6, 2024Jun 6, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
66,36569,065Jan 10, 2024Mar 1, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
99,55099,550Jan 10, 2024Mar 1, 2024View →
IRON
DISC MEDICINE, INC.
PURCHASE
Chief Executive Officer
2,700$1.01$2.7K2,700Dec 29, 2023Jan 3, 2024View →
IRON
DISC MEDICINE, INC.
SALE
Chief Executive Officer
2,700241,211Dec 29, 2023Jan 3, 2024View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
230,000230,000Nov 28, 2023Nov 29, 2023View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
132,002132,002Dec 29, 2022Jan 3, 2023View →
Other insiders · IRON
Loading peer insiders…
About this filer
CIK 0001586788
ROLE
Chief Executive Officer
PRIMARY
IRON
COMPANIES
2
ACTIVE SINCE
Dec 2022
MARKETPEEL · /INSIDER/0001586788DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback